Myelin

Myelin - most related articles:

- Multiple sclerosis treatment from fat stem cells - 3.3
- Low vitamin D levels seen as multiple sclerosis risk for African Americans - 3.2
- New MS drug rituximab shows promise for multiple sclerosis - 3.1
- New drug to improve walking ability in multiple sclerosis people - 2.7
- Smoking leads to rapid progression of multiple sclerosis - 2.2

Myelin articles

29 new genetic variants linked to multiple sclerosis
Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of a very debilitating neurological disease. Many of the genes implicated in the study are relevant to the immune system, shedding light onto the immunological pathways that underlie the development of multiple sclerosis.

Low vitamin D levels seen as multiple sclerosis risk for African Americans
Vitamin D levels in the blood are lower in African Americans who have the disease, compared to African Americans who do not, revealed by researchers exploring the connection between vitamin D and multiple sclerosis in African Americans.

GM-CSF required for the immune attack in multiple sclerosis
The neutralization of the cytokine GM-CSF could halt the development of multiple sclerosis, demonstrated by the research team of the immunologist Burkhard Becher at the University of Zurich in an animal model.

Ampyra, dalfampridine approved for multiple sclerosis patients
The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS).

Smoking increases brain lesions and brain shrinkage in MS
People who smoke and have multiple sclerosis (MS) may be at increased risk of brain shrinkage and increased brain lesions related to the disease, revealed by researchers.

UK's MS Society supports Carers Week
New research launched to mark the start of national Carers Week (8-13 June) shows that almost three-quarters (74%) of carers have reached breaking point due to the pressures of their caring role.

Breastfeeding reduces multiple sclerosis relapse in women
Women with multiple sclerosis who breastfeed exclusively for at least two months appear less likely to experience a relapse within a year after their baby's birth, according to a report that will appear in the August print issue of Archives of Neurology, one of the JAMA/Archives journals.

New drug to improve walking ability in multiple sclerosis people
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that the U.S. Food and Drug Administration (FDA) has accepted the Fampridine-SR New Drug Application (NDA) for filing, assigning Priority Review and a Prescription Drug User Fee Act (PDUFA) date of October_22, 2009.

8 Myelin articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.17